Lihua Qiu
Sun Yat-sen University(CN)University of California, San Francisco(US)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Renji Hospital(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Neijiang Normal University(CN)State Key Laboratory of Oncogene and Related Genes(CN)Sun Yat-sen University Cancer Center(CN)Institute of Hematology & Blood Diseases Hospital(CN)Leukemia and Lymphoma Society(US)University of Minnesota Children's Hospital(US)State Key Laboratory of Oncology in South ChinaSouthern Medical University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral-associated cancers and disorders, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer(2021)91 cited
- → Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium(2015)83 cited
- → Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells(2016)64 cited
- → Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL(2022)59 cited
- → APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations(2022)58 cited
- → Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy